SCHEMBL19909545

SCHEMBL19909545

Cc1cc(-c2c(-n3c4ccccc4c4ccc(C#N)cc43)cc(C#N)cc2-n2c3ccccc3c3ccc(C#N)cc32)cc(C)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
ABCG2 Q9UNQ0 2/20 0.34
GRM5 P41594 1/20 0.34
TDP2 O95551 2/20 0.33
JAK2 O60674 1/20 0.32
PRKD3 O94806 1/20 0.32
ABL1 P00519 1/20 0.32
EGFR P00533 1/20 0.32
ERBB2 P04626 1/20 0.32
LCK P06239 1/20 0.32
CDK1 P06493 1/20 0.32
CSF1R P07333 1/20 0.32
LYN P07948 1/20 0.32
RET P07949 1/20 0.32
KIT P10721 1/20 0.32
FGFR1 P11362 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909546 0.94 CYP11B2 (0.37) CYP11B1CYP11B2ABCG2GRM5TDP2
SCHEMBL19909538 0.92 PDE9A (0.35) PTGER4ABCG2GRM5EGFRKDM4E
SCHEMBL19909390 0.91 PTGER4 (0.33) PTGER4ABCG2GRM5ATMKDM4E
SCHEMBL19913270 0.91 PTGER4 (0.33) PTGER4ABCG2GRM5ATMKDM4E
SCHEMBL19909495 0.90 ALDH1A3 (0.38) ABCG2CLK4IRAK4MEN1KMT2A
SCHEMBL19909110 0.90 IRAK4 (0.33) PTGER4IRAK4MEN1KMT2AATM
SCHEMBL19909387 0.90 MEN1 (0.35) PTGER4ABCG2GRM5IRAK4MEN1
SCHEMBL19909129 0.89 STS (0.34) PTGER4CYP11B1CYP11B2MEN1KMT2A
SCHEMBL22563504 0.88 ABCG2 (0.39) PTGER4CA1CA2ABCG2GRM5
SCHEMBL19913272 0.88 PTGER4 (0.34) PTGER4GRM5CSNK1DKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 PTGER4 1123/4885CA1 1885/4885CA2 1268/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 PTGER4 1123/4885CA1 1885/4885CA2 1268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.